Member Info for itsallamess

John, you will have to be more specific... what are you on talig about?

Jedi, did you email faron?

https://www.proactiveinvestors.co.uk/companies/news/906612/faron-pharma-cash-injection-will-fund-development-of-cancer-drug-906612.html

Times 5

Someone is loading up

Athough I'm very happy with a gradual rise everyday rather than a massive surge.

We may see a surge in SP this afternoon

Drop a tr1 and let us see who has bout 9.5% of faron

Fully funded for 12 months... Which will included all the new sites to test clevegen.

There is another 10% of shares availible to place if they want. Could these be for a duel listing on the Nordic market?

Ted

Have you an issue with me?

Ted

Why was what dismissed? Can you ckaufy what your trying to say.?

Can't imagine any II keeping their holding in farn a secret.. They will publish somewhere...

Zen
That's what I'm talking about.

Fully funded For 12 months... SP will only rise to its true value from here!

Bring on opening bell

That's correct what Terryali broker said.. Question is how did he know?

Cebo

Think you read my comment wrong.

I'm talking about what a partner wants before investing or what faron wants from a partner and further tests of Clevegen will provide that. :)

So is this a indication of what a partner wants before buying in... More clarification of clevegen full potential?

Or do faron want more info on clevegen so they can specify their goals? Either more money or a level of control over the drug with a partner on board!

"This financing will allow us to further progress our clinical programme on Clevegen with a view to clarifying its full potential, either alone or in combination with existing cancer treatments. This is very important as many, if not all, cancer patients have reduced immune capacity to defend them against cancer spread and may potentially be focal information in terms of specifying our goals for the ongoing partnering discussions."

We will need to see if any declare a TR1

If there are some below 3% there must be a way of finding out who?

Markku Jalkanen, CEO of Faron Pharmaceuticals said: “TAMs have been recognised by scientists for years as a key control element in cancer immune biology. The recent licensing deal for up to $1.74 billion between Five Prime and Bristol-Myers Squibb, which included an upfront payment of $350 million for a Phase I trial in immuno-oncology, demonstrates the commercial potential to Faron for the successful development and commercialisation of Clevegen.

Cj.. I'm half bald so I still have a bit to go :)

Cj where's the fun in that :)

I up my opening in to rising to 350 before the RNS drops :)